Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Eli Lilly Says FDA Delays Decision on Alzheimer's Drug
07:21am, Friday, 08'th Mar 2024
The FDA plans to hold a special committee to discuss the Phase 3 trial results of donanemab.
FDA Delays Decision On Eli Lilly's Alzheimer Drug
07:08am, Friday, 08'th Mar 2024
The FDA will hold an advisory panel for Eli Lilly's Alzheimer drug donanemab, delaying approval beyond the first quarter. Lilly stock fell.
3 Stocks Mario Gabelli Is Betting on Big
05:45pm, Thursday, 07'th Mar 2024
Successful investor Mario Gabelli attained billionaire status primarily by investing his and his client's money. He became well-known in the 1980s for making successful picks in media and telecom sect
Lilly (LLY) Up 7.5% Since Last Earnings Report: Can It Continue?
12:37pm, Thursday, 07'th Mar 2024
Lilly (LLY) reported earnings 30 days ago. What's next for the stock?
Lilly finds bacteria, other impurities in Mounjaro, Zepbound knockoffs
10:22am, Thursday, 07'th Mar 2024
Eli Lilly said on Thursday it has found bacteria and high levels of impurities in products claiming to be compounded versions of tirzepatide, the active ingredient in its popular diabetes drug Mounjar
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
06:22am, Thursday, 07'th Mar 2024
Novo Nordisk shares climbed 5% on Thursday morning after the Danish pharmaceutical giant reported positive early trial data for a new weight loss drug.
Eli Lilly (LLY) Might Not Meet Demand for Diabetes & Weight Loss Drugs
05:47pm, Wednesday, 06'th Mar 2024
Eli Lilly (LLY) will likely not meet the demand for diabetes and weight loss drugs in 2024. The Eli Lilly CFO noted that increases in production capacity will take time.
Eli Lilly and Co (LLY) Cowen's 44th Annual Health Care Conference (Transcript)
02:15pm, Wednesday, 06'th Mar 2024
Eli Lilly and Co (NYSE:LLY ) Cowen's 44th Annual Health Care Conference March 6, 2024 9:10 AM ET Company Participants Anat Ashkenazi - EVP & CFO Andrew Adams - Vice President of New Therapeutic Modali
Trillion-Dollar Threshold: The Next 3 Stocks Ready to Rise
01:12pm, Wednesday, 06'th Mar 2024
Seriously, how much longer before Nvidia (NASDAQ: NVDA ) overtakes Microsoft (NASDAQ: MSFT ) as the most valuable company in the world? The chipmaker just surpassed Saudi Aramco to become the third-mo
Is Viking Therapeutics Stock a Better Buy Than Eli Lilly and Novo Nordisk After the Latest Weight-Loss Drug News?
05:50am, Wednesday, 06'th Mar 2024
Investors are excited about the opportunity for Viking's experimental weight-loss drug VK2735. Viking doesn't compare favorably against Lilly and Novo Nordisk in most categories.
Dyne: H2 2024 Muscle Disease Data Could Boost Value
02:48pm, Tuesday, 05'th Mar 2024
Dyne: H2 2024 Muscle Disease Data Could Boost Value
Prediction: Eli Lilly and Novo Nordisk Stock Could Just be Getting Started. Here's Why
09:53am, Tuesday, 05'th Mar 2024
Eli Lilly and Novo Nordisk stock each rose over 50% in 2023 thanks to their diabetes treatments. Industry research suggests the diabetes market will continue to grow for decades to come.
Better Weight Loss Drug Stock: Viking Therapeutics vs. Eli Lilly
06:15am, Tuesday, 05'th Mar 2024
Anti-obesity medicines are currently a tremendously lucrative market. Viking Therapeutics is ascendant after publishing strong phase 2 data.
Eli Lilly (LLY) Increases Despite Market Slip: Here's What You Need to Know
06:51pm, Monday, 04'th Mar 2024
In the latest trading session, Eli Lilly (LLY) closed at $792.28, marking a +1.3% move from the previous day.
It's Time! 3 Dodgy Pharma Stocks to Sell in February
10:06am, Monday, 04'th Mar 2024
Much like Big Tech companies ride the AI hype, pharma stocks are counting on valuation boosts from big drug hits and FDA approvals. This anticipation, however, brings to light the importance of discer
